Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
An. bras. dermatol ; An. bras. dermatol;95(5): 615-618, Sept.-Oct. 2020. graf
Artigo em Inglês | LILACS, Coleciona SUS | ID: biblio-1130930

RESUMO

Abstract Biological therapies, including anti-TNF agents, are important in the treatment of various chronic inflammatory diseases, including psoriasis, rheumatoid arthritis or inflammatory bowel disease. The increased use of these drugs translates into an increasing awareness of its adverse effects, which include malignancy. In this paper, we describe the case of a 28-year-old woman who developed a spitzoid melanocytic tumor after starting infliximab therapy for ulcerative colitis. The evidence for causality between anti-TNF and melanocytic proliferations is still sparse; nonetheless, treatment-associated immunosuppression seems to play a key role in this phenomenon. Therefore, a regular follow-up with a rigorous skin examination is essential in these patients. Noninvasive techniques such as dermoscopy or reflectance confocal microscopy are particularly useful diagnostic tools in these circumstances.


Assuntos
Humanos , Feminino , Adulto , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/induzido quimicamente , Neoplasias Cutâneas/tratamento farmacológico , Nevo de Células Epitelioides e Fusiformes/induzido quimicamente , Fator de Necrose Tumoral alfa , Diagnóstico Diferencial , Infliximab/efeitos adversos
2.
An Bras Dermatol ; 95(5): 615-618, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32711929

RESUMO

Biological therapies, including anti-TNF agents, are important in the treatment of various chronic inflammatory diseases, including psoriasis, rheumatoid arthritis or inflammatory bowel disease. The increased use of these drugs translates into an increasing awareness of its adverse effects, which include malignancy. In this paper, we describe the case of a 28-year-old woman who developed a spitzoid melanocytic tumor after starting infliximab therapy for ulcerative colitis. The evidence for causality between anti-TNF and melanocytic proliferations is still sparse; nonetheless, treatment-associated immunosuppression seems to play a key role in this phenomenon. Therefore, a regular follow-up with a rigorous skin examination is essential in these patients. Noninvasive techniques such as dermoscopy or reflectance confocal microscopy are particularly useful diagnostic tools in these circumstances.


Assuntos
Nevo de Células Epitelioides e Fusiformes , Neoplasias Cutâneas , Adulto , Diagnóstico Diferencial , Feminino , Humanos , Infliximab/efeitos adversos , Nevo de Células Epitelioides e Fusiformes/induzido quimicamente , Neoplasias Cutâneas/induzido quimicamente , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/tratamento farmacológico , Fator de Necrose Tumoral alfa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA